XNAS:AMGN Amgen Inc Insider Activity 4 Filing - 7/31/2012

Effective Date 7/31/2012

XNAS:AMGN (Amgen Inc): Fair Value Estimate
Premium
XNAS:AMGN (Amgen Inc): Consider Buying
Premium
XNAS:AMGN (Amgen Inc): Consider Selling
Premium
XNAS:AMGN (Amgen Inc): Fair Value Uncertainty
Premium
XNAS:AMGN (Amgen Inc): Economic Moat
Premium
XNAS:AMGN (Amgen Inc): Stewardship
Premium
 
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Dittrich Thomas J.W.
  2. Issuer Name and Ticker or Trading Symbol
AMGEN INC [AMGN]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
VP, Finance & CAO
(Last)
(First)
(Middle)
ONE AMGEN CENTER DRIVE
3. Date of Earliest Transaction (Month/Day/Year)
07/31/2012
(Street)

THOUSAND OAKS, CA 91320
4. If Amendment, Date Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/31/2012   M   25,000 A $69.83 38,721 D  
Common Stock 07/31/2012   M   3,000 A $42.13 41,721 D  
Common Stock 07/31/2012   M   2,000 A $50.44 43,721 D  
Common Stock 07/31/2012   M   2,150 A $58.43 45,871 D  
Common Stock 07/31/2012   S   32,150 D $82.687(1) 13,721(2)(3) D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Nqso (Right to Buy) $69.83 07/31/2012   M     25,000 05/15/2007 05/15/2013 Common Stock 25,000 $ 0 0 D  
Nqso (Right to Buy) $42.13 07/31/2012   M     3,000 04/29/2009 04/29/2015 Common Stock 3,000 $ 0 0 D  
Nqso (Right to Buy) $50.44 07/31/2012   M     2,000 04/28/2010 04/28/2016 Common Stock 2,000 $ 0 2,000 D  
Nqso (Right to Buy) $58.43 07/31/2012   M     2,150 04/26/2011 04/26/2020 Common Stock 2,150 $ 0 4,300 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Dittrich Thomas J.W.
ONE AMGEN CENTER DRIVE
THOUSAND OAKS, CA 91320
      VP, Finance & CAO  

Signatures

 /s/ Thomas J.W. Dittrich   07/31/2012
** Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The price reported is an average price. The prices ranged from $82.67 to $82.75 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer.
(2) The shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 286 RSUs which fully vest on 4/28/2013; 615 RSUs which vest in annual installments of 307 on 4/26/2013 and 308 on 4/26/2014; 1,714 RSUs which vest in annual installments of 565, 566 and 583 on 4/25/2013, 4/25/2014 and 4/25/2015, respectively; and 1,400 RSUs which vest in two equal installments of 462 each on 4/27/2014 and 4/27/2015 and one installment of 476 on 4/27/2016. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
(3) These shares include 7 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

XNAS:AMGN Amgen Inc Insider Activity 4 Filling

Amgen Inc XNAS:AMGN Stock - Get Insider Activity SEC Filing of Amgen Inc XNAS:AMGN stocks, including company profile, shares outstanding, strategy, business segments, operations, officers, consolidated financial statements, financial notes and ownership information.

XNAS:AMGN Amgen Inc Insider Activity 4 Filing - 7/31/2012
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices Title |  Date |  Company |  Symbol |  Interest |  Popularity

Previous: XNAS:AMGN Amgen Inc Insider Activity 4 Filing - 7/30/2012  |  Next: XNAS:AMGN Amgen Inc Insider Activity 4 Filing - 7/31/2012